Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.30 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10019549 | 0.97 | CTSL (0.40) | CTSLCTSSCTSKGABRA1GABRB2 | |
| SCHEMBL10020112 | 0.96 | CTSL (0.36) | CTSLCTSSCTSKFGFR1FGFR2 | |
| SCHEMBL10019658 | 0.94 | CTSL (0.39) | CTSLCTSSCTSKGABRA1GABRB2 | |
| SCHEMBL10019997 | 0.93 | CTSS (0.46) | CTSLCTSSCTSKGABRA1GABRB2 | |
| SCHEMBL10020131 | 0.92 | CTSL (0.40) | CTSLCTSSCTSKGABRA1GABRB2 | |
| SCHEMBL10019838 | 0.91 | GABRA1 (0.36) | CTSLCTSSCTSKGABRA1GABRB2 | |
| SCHEMBL10020025 | 0.88 | GABRA1 (0.37) | CTSLCTSSCTSKGABRA1GABRB2 | |
| SCHEMBL10020019 | 0.87 | GABRA1 (0.38) | CTSLCTSSCTSKGABRA1GABRB2 | |
| SCHEMBL10020099 | 0.86 | CTSL (0.33) | CTSLCTSSCTSKGABRA1GABRB2 | |
| SCHEMBL10020175 | 0.86 | CTSS (0.36) | CTSLCTSSCTSKGABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2669263-B1 | COMPOUND CONTAINING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2017-11-22 | — | — | EP | disclosed |
| US-9193908-B2 | Compound having dihydrophenanthrene, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2015-11-24 | — | — | US | disclosed |
| US-9193908-B2 | Compound having dihydrophenanthrene, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2015-11-24 | — | — | US | disclosed |
| US-20130240784-A1 | COMPOUND HAVING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2013-09-19 | — | — | US | disclosed |
| US-20130240784-A1 | COMPOUND HAVING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2013-09-19 | — | — | US | disclosed |
| WO-2012086437-A1 | COMPOUND CONTAINING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY | JNC株式会社 (JP) | 2012-06-28 | — | — | WO | disclosed |